Q1 2021 Vascular Biogenics Ltd Earnings Call Transcript
Greetings. Welcome to VBL Therapeutics First Quarter 2021 Earnings Call. (Operator Instructions) Please note this conference is being recorded.
I would now like to turn the conference over to Lee Roth with Burns McClellan. Thank you. You may begin.
Thank you, Cherry. Good morning, everyone, and thank you for joining today's VBL Therapeutics First Quarter 2021 Financial Results and Corporate Update Conference call. Leading the call this morning will be Professor Dror Harats, Chief Executive Officer; and Amos Ron, Chief Financial Officer. A press release with the company's financial results was issued earlier this morning and is available on the Investor Relations page of the company's website at vblrx.com.
Before I turn the call over to management, I'd like to remind everyone that during this conference call, forward-looking statements made by management are intended to fall within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, and and Section 21E of the Securities Exchange Act of 1934 as amended. As set
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |